Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma
Cellular Oncology · 2024
DOI: 10.1007/s13402-024-00967-1 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cellular Oncology, 2024. Verfasst von Hongsheng Wang und 17 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, 100 Haining Road, Shanghai, 200080, China. Hauptthemen laut MEDLINE: Osteosarcoma, Glutamine, YAP-Signaling Proteins, Adaptor Proteins, Signal Transducing. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Orthopedics, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, 100 Haining Road, Shanghai, 200080, China.
- Shanghai Bone Tumor Institution, Shanghai, China.
- National Research Center for Translational Medicine (Shanghai), State Key Laboratory of Medical Genomics, Shanghai Institute of Hematology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, Ch…
- Department of Biochemistry and Molecular Cell Biology, Shanghai Key Laboratory for Tumor Microenvironment and Inflammation, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
- Department of Laboratory Animal Center, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
- Department of Pathology, Shanghai General Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Wang, H., Tao, Y., Han, J., Shen, J., Mu, H., Wang, Z., Wang, J., Jin, X., Zhang, Q., Yang, Y., Lin, J., Sun, M., Ma, X., Ren, L., LeBlanc, A. K., Xu, J., Hua, Y., & Sun, W. (2024). Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma. Cellular Oncology. https://doi.org/10.1007/s13402-024-00967-1
Vancouver
Wang H, Tao Y, Han J, Shen J, Mu H, Wang Z, et al. Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma. Cellular Oncology. 2024. doi:10.1007/s13402-024-00967-1
BibTeX
@article{Wang2024,
author = {Wang, Hongsheng and Tao, Yining and Han, Jing and Shen, Jiakang and Mu, Haoran and Wang, Zhuoying and Wang, Jinzeng and Jin, Xinmeng and Zhang, Qi and Yang, Yuqin and Lin, Jun and Sun, Mengxiong and Ma, Xiaojun and Ren, Ling and LeBlanc, Amy K and Xu, Jing and Hua, Yingqi and Sun, Wei},
title = {Disrupting YAP1-mediated glutamine metabolism induces synthetic lethality alongside ODC1 inhibition in osteosarcoma},
journal = {Cellular Oncology},
year = {2024},
doi = {10.1007/s13402-024-00967-1}
}
EUVIMED